CDMC Amsterdam
Managing Diabetes and Cardiovascular Risk: Updates & perspectives in 2010
Scientific agenda
The evolution of treatment of type 2 diabetes: Where are we now?
Cees Tack, University of Nijmegen The Netherlands
Diabetes & cardiovascular risk: A lifetime risk challenge
John Deanfield , London, United Kingdom
Hypoglycaemia in Type 2 diabetes:Frequency, morbidity and mortality
Simon Heller, Sheffield, United Kingdom
Sustained glycaemic control in diabetes: How and what is the time to act?
Thomas Forst, Mainz, Germany
Managing hypertension in type 2 diabetes
Gordon McInnes, Glasgow, United Kingdom
Evidence vs. opinion based guidelines for the management of type 2 diabetic patients
Guntram Schernthaner, Vienna, Austria
Update on clinical trials in type 2 diabetes: What is the role of TZD’s?
John Betteridge, London, United Kingdom
Study of oral drugs for type 2 diabetes and all cause mortality in General Practice: what are the implications?
Ioanna Tzoulaki, London, United Kingdom
Protecting the kidney in diabetes
Gordon McInnes, Glasgow, United Kingdom
Management of dyslipidemia in type 2 diabetes
John Betteridge, London, United Kingdom
The challenge for type 2 diabetes: Targeting obesity in the young
John Deanfield, London, United Kingdom
Share this page with your colleagues and friends: